97 related articles for article (PubMed ID: 24974147)
21. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
22. Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas.
Wilson WH; Teruya-Feldstein J; Fest T; Harris C; Steinberg SM; Jaffe ES; Raffeld M
Blood; 1997 Jan; 89(2):601-9. PubMed ID: 9002964
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic role of SGTA in human breast carcinoma correlates with tumor cell proliferation.
Zhu T; Ji Z; Xu C; Peng Z; Gu L; Zhang R; Liu Y
J Mol Histol; 2014 Dec; 45(6):665-77. PubMed ID: 25027991
[TBL] [Abstract][Full Text] [Related]
24. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
25. [Study of dual rearrangements of lymphocytic antigen receptor genes in non-Hodgkin lymphoma].
Zhang XF; Zhou R; Yang YP; Mao ZR; Yang SY; Zhang SJ
Zhonghua Xue Ye Xue Za Zhi; 2004 Oct; 25(10):583-7. PubMed ID: 15634589
[TBL] [Abstract][Full Text] [Related]
26. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.
Ristamäki R; Joensuu H; Söderström KO; Jalkanen S
J Pathol; 1995 Jul; 176(3):259-67. PubMed ID: 7545748
[TBL] [Abstract][Full Text] [Related]
27. Silencing of LIMD1 promotes proliferation and reverses cell adhesion-mediated drug resistance in non-Hodgkin's lymphoma.
Tang J; Zhu L; Huang Y; Shi B; Zhang S; Gu L; Zhao J; Deng M; Zhu J; Xun H; Wang Y; Wang C
Oncol Lett; 2019 Mar; 17(3):2993-3000. PubMed ID: 30854077
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
[TBL] [Abstract][Full Text] [Related]
29. MDR-1 expression in non-Hodgkin's lymphomas is unrelated to treatment intensity or response to therapy.
Finnegan MC; Royds J; Goepel JR; Lorigan P; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Jul; 18(3-4):297-302. PubMed ID: 8535196
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
31. Spectrum of malignant lymphomas in Klang Hospital, a public hospital in Malaysia.
Peh SC; Kim LH; Thanaletchimy N; Chai SP; Poppema S
Malays J Pathol; 2000 Jun; 22(1):13-20. PubMed ID: 16329532
[TBL] [Abstract][Full Text] [Related]
32. Expression of the CD31 antigen in normal B-cells and non Hodgkin's lymphomas.
Stacchini A; Chiarle R; Antinoro V; Demurtas A; Novero D; Palestro G
J Biol Regul Homeost Agents; 2003; 17(4):308-15. PubMed ID: 15065759
[TBL] [Abstract][Full Text] [Related]
33. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
34. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.
Zhang C; Duan X; Xu L; Ye J; Zhao J; Liu Y
Breast Cancer Res Treat; 2012 Dec; 136(3):739-48. PubMed ID: 23117856
[TBL] [Abstract][Full Text] [Related]
36. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
[TBL] [Abstract][Full Text] [Related]
37. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54).
Horst E; Meijer CJ; Radaszkiewicz T; Ossekoppele GJ; Van Krieken JH; Pals ST
Leukemia; 1990 Aug; 4(8):595-9. PubMed ID: 1974938
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity in relation to pro- and anti-apoptotic protein expression in high grade non-Hodgkin's lymphomas.
MacNamara B; Wang W; Chen Z; Hou M; Mazur J; Gruber A; Porwit-MacDonald A
Haematologica; 2001 Apr; 86(4):386-93. PubMed ID: 11325644
[TBL] [Abstract][Full Text] [Related]
39. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression.
Villuendas R; Sánchez-Beato M; Martínez JC; Saez AI; Martinez-Delgado B; García JF; Mateo MS; Sanchez-Verde L; Benítez J; Martínez P; Piris MA
Am J Pathol; 1998 Sep; 153(3):887-97. PubMed ID: 9736037
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of E2F-1 in non-Hodgkin's lymphomas: a survey of 124 cases.
Lai R; Medeiros LJ; Coupland R; McCourty A; Brynes RK
Mod Pathol; 1998 May; 11(5):457-63. PubMed ID: 9619599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
